The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis

The prognostic value of Bcl-2-like protein 11 (BIM) deletion polymorphism for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) treatment in non-small cell lung cancer (NSCLC) were reported. However, the results remained controversial. Thus, we did this systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Wei, Tao, Xia, Wei, Hua, Chen, Wan-sheng, Li, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694859/
https://www.ncbi.nlm.nih.gov/pubmed/26325082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694859/
https://www.ncbi.nlm.nih.gov/pubmed/26325082

Ejemplares similares